Articles tagged with “biotech-capital-outlook”

2026 Biotech Capital Outlook: Blackstone's $6.3B Fund VI

Analyze the 2026 biotech capital outlook, detailing Blackstone's record $6.3B Life Sciences Fund VI, VC funding trends, biopharma M&A, and market recovery.

80 min read

4/26/2026

biotech capital outlook blackstone life sciences biotech funding 2026 biopharma m&a life sciences investment venture capital biotech ipo trends